TipRanks
Advertisement
Advertisement
5-star BMO analyst upgrades Ionis ahead of Q3 report
PremiumThe Fly5-star BMO analyst upgrades Ionis ahead of Q3 report
20h ago
Ionis Pharmaceuticals upgraded to Outperform from Market Perform at BMO Capital
Premium
The Fly
Ionis Pharmaceuticals upgraded to Outperform from Market Perform at BMO Capital
20h ago
3 Healthcare Stocks with Strong Buy Ratings and Double-Digit Upside
Premium
Market News
3 Healthcare Stocks with Strong Buy Ratings and Double-Digit Upside
1d ago
Ionis Pharmaceuticals says CHMP adopts positive opinion on tryngolza
PremiumThe FlyIonis Pharmaceuticals says CHMP adopts positive opinion on tryngolza
6d ago
Ionis Pharmaceuticals upgraded to Buy from Neutral at UBS
Premium
The Fly
Ionis Pharmaceuticals upgraded to Buy from Neutral at UBS
8d ago
AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
Premium
Market News
AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
15d ago
Roche’s Genentech reports ‘positive’ results from Phase 3 Imagination study
PremiumThe FlyRoche’s Genentech reports ‘positive’ results from Phase 3 Imagination study
29d ago
Ionis announces Phase 3 FUSION study of ulefnersen met primary endpoint
Premium
The Fly
Ionis announces Phase 3 FUSION study of ulefnersen met primary endpoint
1M ago
Ionis Pharmaceuticals price target lowered to $70 from $76 at JPMorgan
Premium
The Fly
Ionis Pharmaceuticals price target lowered to $70 from $76 at JPMorgan
1M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―